Cross-sectional analysis of lymph node patterns shows high non-neoplastic lesion rates, highlighting diagnosis implications.
Background: Lymphadenopathy, which is defined as the swelling of lymph nodes, is a frequent clinicalpresentation with a wide differential diagnosis that includes both cancers and benign reactive processes. Fineneedle aspiration cytology (FNAC) is a less invasive, economical diagnostic method for assessinglymphadenopathy, facilitating the identification of various causes.Objective: The objective of this study was to evaluate the cytomorphological spectrum of enlarged lymph nodesin patients at a tertiary healthcare facility, emphasizing the incidence of neoplastic and non-neoplastic lesions andtheir distribution across various age groups and genders.Methodology: A cross-sectional research was performed in the Department of Pathology at Darbhanga MedicalCollege and Hospital, Bihar, India. Seventy-four individuals exhibiting lymphadenopathy received fine needleaspiration cytology (FNAC). Aspirates were processed and stained with conventional cytological methodologies,including Hematoxylin & Eosin, Papanicolaou, Giemsa, and Ziehl-Neelsen stains. Cytological diagnosis wereclassified into non-neoplastic and neoplastic lesions, with additional sub classification as warranted.Results: The largest prevalence of lymphadenopathy occurred in the 21–30 years age range (20.3%), with a malepreponderance (56.8%). The cervical region was the most often impacted area (54.1%). Non-neoplastic lesionscomprised 70.2% of cases, with reactive lymphoid hyperplasia (32.4%) and tuberculous lymphadenitis (27.0%)as the most prevalent. Neoplastic lesions constituted 29.8% of patients, with metastatic carcinoma (13.5%) beingthe most prevalent, followed by Non-Hodgkin’s lymphoma (6.7%) and Hodgkin’s lymphoma (5.4%).Conclusion: FNAC serves as an efficient preliminary diagnostic tool for assessing lymphadenopathy, offeringsignificant insights into the underlying disease. The research indicates an increased occurrence of non-neoplasticdiseases, including reactive hyperplasia and TB, among the examined group. The prevalence of metastaticcarcinoma highlights the necessity of evaluating secondary malignancies in differential diagnosis, particularly inelderly individuals.
No takes yet. Share an insight, caveat, or question.
Kumar et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: